C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/44 (2006.01) C07D 213/38 (2006.01) C07D 401/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 471/10 (2006.01) C07D 491/10 (2006.01) C07D 495/10 (2006.01)
Patent
CA 2342882
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by structural formula (A) and physiologically acceptable salts thereof.
L'invention concerne un procédé pour traiter un sujet souffrant d'une maladie associée à la capture et/ou l'activation de leucocytes aberrants. Ce procédé consiste à administrer au sujet une quantité thérapeutiquement efficace d'un composé représenté par la formule structurelle (A) et de sels physiologiquement acceptables de ce dernier.
Luly Jay R.
Nakasato Yoshisuke
Ohshima Etsuo
Borden Ladner Gervais Llp
Kyowa Hakko Kogyo Co. Ltd.
Millennium Pharmaceuticals Inc.
LandOfFree
Chemokine receptor antagonists and methods of use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemokine receptor antagonists and methods of use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine receptor antagonists and methods of use therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1778792